1. Department of Urology, Qilu Hospital of Shandong University, Jinan, China 2. Division of Gastroenterology, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China *Zonglong Wu and Muru Wang contributed equally to this article.
✉ Corresponding authors: Yan Li, Department of Urology, Qilu Hospital of Shandong University, 107 Wenhuaxi Road, Jinan, 250012, China, E-mail: yanliedu.cn. Benkang Shi, Department of Urology, Qilu Hospital of Shandong University, 107 Wenhuaxi Road, Jinan, 250012, China, E-mail: bkang68edu.cn.More
Citation:
Wu Z, Wang M, Liu Q, Liu Y, Zhu K, Chen L, Guo H, Li Y, Shi B. Identification of gene expression profiles and immune cell infiltration signatures between low and high tumor mutation burden groups in bladder cancer. Int J Med Sci 2020; 17(1):89-96. doi:10.7150/ijms.39056. https://www.medsci.org/v17p0089.htm
Bladder cancer is one of the most commonly diagnosed tumors and is results from the accumulation of somatic mutations in the DNA. Tumor mutation burden (TMB) has been associated with cancer immunotherapeutic response. In this study, we attempted to explore the correlation between TMB and cancer prognosis. Identify the different expressed genes and immune cell infiltration signatures between low and high TMB group. Mutation data, gene expression profiles and clinical data were downloaded from The Cancer Genome Atlas (TCGA) database. Patients were divided into high and low TMB groups, allowing differentially expressed genes (DEGs) to be identified. Functional enrichment and protein-protein interaction (PPI) network analysis were used to identify the functions of the DEGs. And immune cell infiltration signatures were evaluated by CIBERSORT algorithm. These results shown that high TMB was significantly associated with prognosis. We obtained a list of TMB related genes which may influence the infiltrations of immune cells. We also found a higher proportion of CD8 T cells, CD4 T cells and NK cells in the high TMB group. Our data suggest that higher TMB tends to promote the infiltrations of T cells and NK cells and patients with higher TMB may achieve a more favorable prognosis in bladder cancer.
Wu, Z., Wang, M., Liu, Q., Liu, Y., Zhu, K., Chen, L., Guo, H., Li, Y., Shi, B. (2020). Identification of gene expression profiles and immune cell infiltration signatures between low and high tumor mutation burden groups in bladder cancer. International Journal of Medical Sciences, 17(1), 89-96. https://doi.org/10.7150/ijms.39056.
ACS
Wu, Z.; Wang, M.; Liu, Q.; Liu, Y.; Zhu, K.; Chen, L.; Guo, H.; Li, Y.; Shi, B. Identification of gene expression profiles and immune cell infiltration signatures between low and high tumor mutation burden groups in bladder cancer. Int. J. Med. Sci. 2020, 17 (1), 89-96. DOI: 10.7150/ijms.39056.
NLM
Wu Z, Wang M, Liu Q, Liu Y, Zhu K, Chen L, Guo H, Li Y, Shi B. Identification of gene expression profiles and immune cell infiltration signatures between low and high tumor mutation burden groups in bladder cancer. Int J Med Sci 2020; 17(1):89-96. doi:10.7150/ijms.39056. https://www.medsci.org/v17p0089.htm
CSE
Wu Z, Wang M, Liu Q, Liu Y, Zhu K, Chen L, Guo H, Li Y, Shi B. 2020. Identification of gene expression profiles and immune cell infiltration signatures between low and high tumor mutation burden groups in bladder cancer. Int J Med Sci. 17(1):89-96.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.